Aclaris Therapeutics, a physician-led biopharmaceutical company, entered into a loan and security agreement with Silicon Valley Bank pursuant to which Aclaris has borrowed $11.0 million.
TripActions has raised a debt facility of up to $500 million to launch the industry’s first, end-to-end global corporate travel management and payments platform.
AES Distributed Energy entered into a $341 million debt agreement which provides new capital to be used for permanent debt financing for a portfolio of distributed generation projects throughout the Northeast.
Silicon Valley Bank has hired Emily Barron, Brian Foley and Folake Shasanya to lead warehouse lending across the US and EMEA.
Misonix amended its existing credit facility with SWK Funding to provide an additional $5 million of term loans and closed a new $20 million revolving credit facility with Silicon Valley Bank.
Motus GI Holdings has entered into a $8 million secured term loan with Silicon Valley Bank.
Orchestra BioMed has entered into a $20 million credit facility agreement with Silicon Valley Bank.
OncoCyte amended its loan and security agreement with Silicon Valley Bank pursuant to which Oncocyte obtained a new $3 million secured credit facility.
Luna Innovations entered into a new $10 million revolving credit facility with Silicon Valley Bank.
Barclays Bank, Citibank, HSBC and Silicon Valley Bank provided a revolving credit facility of up to €140 million ($154.4 million) to Keywoods Studios.